News and Resources

Choose an area of interest:

Eosinophilic Asthma Epileptic Encephalopathy Company News

01.01.18

American Society of Hematology: “Dexpramipexole as an oral steriod-sparing agent in hypereosinophilic syndromes”

Discover this News

09.06.17

Knopp Biosciences and APFED Announce Partnership to Advance Awareness of Hypereosinophilic Syndromes

Discover this News

1 2

Knopp Disclaimer

Knopp’s pipeline consists of investigational drug products that have not been approved by the U.S. Food and Drug Administration. These investigational drug products are undergoing clinical study to verify their safety and effectiveness.

News and Resources

Learn More About the Unmet Needs We Strive to Address

Keep Up with Knopp, See What We Are Doing Next

Knopp Disclaimer